Firman Ardiansyah Hartono
Veterinary Medicine Study Program, Faculty of Health, Medicine, and Life Science, Universitas Airlangga, Banyuwangi 68425, East Java, Indonesia.

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

A Critical Assessment of Phytobiotics, Microbial Consortia, and Phage Thera-py for Vibrio parahaemolyticus Control in Aquaculture Syawalina Nailatuz Zahroh; Nadine Aurelie Afiawan Putri; Maulida Mega Silvi; Faradisa Ilmi Shabrina; Firman Ardiansyah Hartono; Nia Nur Aulia; Kinanti Dwi Rahmawati; Alya Launa Afriamanda
Journal of Aquaculture Science Vol 11 No 2 (2026): Journal of Aquaculture Science
Publisher : Airlangga University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/joas.v11i2.98482

Abstract

Vibrio parahaemolyticus is a primary aquaculture pathogen responsible for acute hepatopancreatic necrosis disease (AHPND) in shrimp and severe vibriosis in fin-fish. The widespread emergence of multidrug-resistant strains necessitates a shift from conventional antibiotics toward targeted, sustainable non-antibiotic biocon-trol strategies. This review critically assesses three prominent intervention pillars against V. parahaemolyticus: phytobiotics, microbial consortia, and phage thera-py. Plant derived bioactive compounds (phytobiotics) exhibit strong im-munostimulatory and direct antibacterial properties. Microbial consortia encom-passing probiotics, prebiotics, synbiotics, and biofloc systems enhance host im-mune defense, competitive exclusion, and water quality regulation. Meanwhile, lytic bacteriophages and phage-derived endolysins provide high specificity for targeted pathogen lysis without disrupting beneficial microbiota. Experimental evidence confirms that integrating these three approaches can effectively sup-press bacterial virulence, bolster host survival, and mitigate antimicrobial re-sistance risks. However, their full-scale adoption remains constrained by variable efficacy, environmental stability, and regulatory hurdles in commercial farming operations. Further fieldscale validations and standardized formulation protocols are essential to translate these biocontrol innovations into scalable, practical solu-tions for sustainable aquaculture disease management.